Guardant Health, Inc. (GH)

USD 32.36

(-7.12%)

Gross Profit Summary of Guardant Health, Inc.

  • Guardant Health, Inc.'s latest annual gross profit in 2023 was 336.89 Million USD , up 14.9% from previous year.
  • Guardant Health, Inc.'s latest quarterly gross profit in 2024 Q2 was 104.81 Million USD , up 1.57% from previous quarter.
  • Guardant Health, Inc. reported a annual gross profit of 293.21 Million USD in annual gross profit 2022, up 16.94% from previous year.
  • Guardant Health, Inc. reported a annual gross profit of 250.74 Million USD in annual gross profit 2021, up 29.12% from previous year.
  • Guardant Health, Inc. reported a quarterly gross profit of 103.19 Million USD for 2024 Q1, down -56.31% from previous quarter.
  • Guardant Health, Inc. reported a quarterly gross profit of 85.41 Million USD for 2023 Q3, up 2.54% from previous quarter.

Annual Gross Profit Chart of Guardant Health, Inc. (2023 - 2016)

Historical Annual Gross Profit of Guardant Health, Inc. (2023 - 2016)

Year Gross Profit Gross Profit Growth
2023 336.89 Million USD 14.9%
2022 293.21 Million USD 16.94%
2021 250.74 Million USD 29.12%
2020 194.19 Million USD 35.18%
2019 143.65 Million USD 202.88%
2018 47.42 Million USD 160.26%
2017 18.22 Million USD 483.17%
2016 3.12 Million USD 0.0%

Peer Gross Profit Comparison of Guardant Health, Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD -3421.806%
Prenetics Global Limited 8.82 Million USD -3715.406%
Star Equity Holdings, Inc. 11.92 Million USD -2724.887%
CareDx, Inc 178.32 Million USD -88.922%
Exact Sciences Corporation 1.84 Billion USD 81.745%
Exagen Inc. 29.45 Million USD -1043.726%
Inotiv, Inc. 165.44 Million USD -103.633%
Biodesix, Inc. 36.07 Million USD -833.825%
BioNexus Gene Lab Corp. 1.32 Million USD -25240.091%
Precipio, Inc. 6.01 Million USD -5498.139%
iSpecimen Inc. 5.1 Million USD -6495.567%
Natera, Inc. 492.74 Million USD 31.628%
Aspira Women's Health Inc. 5.26 Million USD -6302.433%
Standard BioTools Inc. 50.45 Million USD -567.782%
23andMe Holding Co. 99.37 Million USD -239.008%
Castle Biosciences, Inc. 174.8 Million USD -92.726%
Personalis, Inc. 18.2 Million USD -1750.264%
Aclaris Therapeutics, Inc. 13.16 Million USD -2458.445%
Applied DNA Sciences, Inc. 5.53 Million USD -5988.373%
OpGen, Inc. -90.69 Thousand USD 371564.485%
T2 Biosystems, Inc. -8.17 Million USD 4223.574%
Myriad Genetics, Inc. 476.4 Million USD 29.283%
ICON Public Limited Company 1.81 Billion USD 81.431%
NeoGenomics, Inc. 244.6 Million USD -37.731%
Star Equity Holdings, Inc. 11.92 Million USD -2724.887%
IDEXX Laboratories, Inc. 2.18 Billion USD 84.616%
RadNet, Inc. 93 Million USD -262.254%
MDxHealth SA 43.92 Million USD -666.91%
Psychemedics Corporation 8.41 Million USD -3904.469%
Illumina, Inc. 2.74 Billion USD 87.722%
Check-Cap Ltd. -212 Thousand USD 159013.208%
Twist Bioscience Corporation 133.34 Million USD -152.642%
DarioHealth Corp. 5.98 Million USD -5529.947%
Fulgent Genetics, Inc. 104.45 Million USD -222.524%
Sera Prognostics, Inc. 96 Thousand USD -350833.333%
ENDRA Life Sciences Inc. -275.45 Thousand USD 122407.053%
OPKO Health, Inc. 318.12 Million USD -5.9%
Medpace Holdings, Inc. 524.5 Million USD 35.769%
Neogen Corporation 463.9 Million USD 27.377%
Intelligent Bio Solutions Inc. 1.42 Million USD -23531.443%
Prenetics Global Limited 8.82 Million USD -3715.406%
Mainz Biomed B.V. 509.65 Thousand USD -66002.237%
bioAffinity Technologies, Inc. 791.61 Thousand USD -42458.062%
Trinity Biotech plc 19.45 Million USD -1632.113%
Neuronetics, Inc. 51.7 Million USD -551.573%
Sotera Health Company 577.15 Million USD 41.628%
bioAffinity Technologies, Inc. 791.61 Thousand USD -42458.062%